Background
\(^{131}\) I is a critical radionuclide in nuclear medicine, particularly for thyroid disorder therapies. Chinese national standards mandate reducing \(^{131}\) I concentrations in radioactive waste liquid to below 10 Bq/L. To address this requirement, rapid and precise quantification of \(^{131}\) I activity is essential for compliance monitoring and clinical safety.
Methods
A detection system integrating a NaI(Tl) crystal and a silicon photomultiplier array was developed to measure the \(^{131}\) I concentrations via its 364.5 keV characteristic \(\gamma \) -ray emissions. The setup incorporates 5 cm oxygen-free copper and 5 cm lead shielding to mitigate external \(\gamma \) -ray interference. Sample analysis utilizes a 50 mL aliquot, with system sensitivity evaluated under varying measurement durations.
Results
Under optimized shielding conditions, the system achieved a minimum detectable activity of 8.0 Bq/L for \(^{131}\) I within a 3-hour measurement period. Extending the acquisition time to 24 hours enhanced sensitivity to 2.8 Bq/L, surpassing the regulatory threshold requirement of 10 Bq/L.
Conclusions
The developed system demonstrates sufficient sensitivity and accuracy for monitoring \(^{131}\) I in radioactive waste liquids, aligning with national emission standards. The time-dependent sensitivity improvement highlights its adaptability for both rapid screening and low-concentration quantification, thus validating its applicability in nuclear medicine waste management.